SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-10-181406
Filing Date
2010-08-06
Accepted
2010-08-06 16:16:54
Documents
4
Period of Report
2010-09-16
Effectiveness Date
2010-08-06

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 991427
2 GRAPHIC g33929g12c39.jpg GRAPHIC 9412
3 GRAPHIC g33929g37r97.jpg GRAPHIC 10333
4 GRAPHIC g33929g97z57.jpg GRAPHIC 7065
  Complete submission text file 0001193125-10-181406.txt   1030260
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12465 | Film No.: 10998633
SIC: 2834 Pharmaceutical Preparations